drugset / Trial / NCT01372670

Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder

NCT01372670

RandomizedSingle-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the effectiveness of hydroxyzine in the treatment of meal-related anxiety in adolescents and young adults 8 to 25 years of age diagnosed with an eating disorder who are underweight. The investigators want to find out if hydroxyzine given before meals will improve meal-related anxiety compared to no hydroxyzine.

Timeline

Start
2012-01
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxyzine Small molecule 10 mg
Subject Hydroxyzine Small molecule 20 mg
Subject Hydroxyzine Small molecule 30 mg